Form D · Venture Capital Fund

Echo Life Sciences Fund, LP

Oklahoma City, OK · CIK 0001860720

Offering snapshot reported Jul 7, 2023 · SEC filing

Reported sold
$12.3M
Offering amount: $50M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 16, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$6.15M$12.3MAug 9, 2021Jul 14, 2022: $7,258,833.00Jul 14, 2022Jul 7, 2023: $12,309,191.00Jul 7, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$7,258,833 → $12,309,191
  • Reported investors8 → 9

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 7, 2023Amendment$12,309,191$5,050,358vs Jul 14, 20229SEC filing
Jul 14, 2022Amendment$7,258,833No comparison8SEC filing
Aug 9, 2021InitialYet to sellNo comparisonNot reportedSEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.1
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-409181

Source: Form D, filed Jul 7, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
N/A Echo Investment Capital, Llc Executive
N/A Echo O Bio Fund I Gp, Llc Promoter
Michael Christian Kanady Executive
Brandon O'gara Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
120 Robert S. Kerr, Suite 701
Oklahoma City, OK, 73102